- Condition: Colorectal Cancer
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Lymphocytic Leukemia, Chronic
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Ulcerative Colitis
Intervention:
Sponsors: Ferring Pharmaceuticals; Ferring Pharmaceuticals; ANGH: Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux de France; CREGG: Club de Réflexion des Cabinets et Groupes d'Hépato-Gastroentérologie
Recruiting - verified May 2012 - Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: Standard of care treatment
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Colorectal Cancer
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Indacaterol 150 µg once-daily via single-dose dry powder inhaler
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Other: Disease Management; Other: Usual site management
Sponsors: Air Liquide Santé International; Air Liquide Santé International; ITEC Services; Lincoln
Recruiting - verified May 2012 - Condition: Breast Cancer
Interventions: Drug: pertuzumab; Drug: capecitabine [Xeloda]; Drug: capecitabine [Xeloda]; Drug: trastuzumab [Herceptin]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: HIV Infections
Intervention: Drug: Tipranavir
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Available - verified May 2012
 |
Join Clinical Trials that are Held in Aix-en-Provence, France |
Clinical Trial Locations 